By Emily Newton, Contributing Writer03.02.22
Artificial intelligence (AI) is increasingly becoming part of pharmaceutical manufacturing. Applying the technology to existing workflows takes time and money. However, it can often pay off. Here are some of the advantages that AI can bring to pharmaceutical drugmakers.
Accelerating the Creation of New Drugs
Research and development efforts must give strong evidence that a new drug would be beneficial for patients. However, that phase can take years. Recent research indicates AI could aid in both the drug discovery and manufacturing efforts of new pharmaceutical products.
A new platform called Pharma.AI enabled a timeframe of only 18 months from the target discovery to the preclinical candidate nomination. Researchers hope the new drug could be a key part of treating idiopathic pulmonary fibrosis, a chronic lung disease.
Succeeding in this area could mean pharmaceu
Accelerating the Creation of New Drugs
Research and development efforts must give strong evidence that a new drug would be beneficial for patients. However, that phase can take years. Recent research indicates AI could aid in both the drug discovery and manufacturing efforts of new pharmaceutical products.
A new platform called Pharma.AI enabled a timeframe of only 18 months from the target discovery to the preclinical candidate nomination. Researchers hope the new drug could be a key part of treating idiopathic pulmonary fibrosis, a chronic lung disease.
Succeeding in this area could mean pharmaceu
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
